2020
Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case–control study
Shen Y, Risch H, Lu L, Ma X, Irwin ML, Lim JK, Taddei T, Pawlish K, Stroup A, Brown R, Wang Z, Jia W, Wong L, Mayne ST, Yu H. Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case–control study. Cancer Causes & Control 2020, 31: 321-332. PMID: 32060838, PMCID: PMC7136513, DOI: 10.1007/s10552-020-01277-1.Peer-Reviewed Original ResearchConceptsRisk of HCCCase-control studyHepatocellular carcinomaRisk factorsHCV infectionHCC riskOdds ratioHepatitis C virus antibodyUnconditional logistic regression modelsElevated HCC riskRapid case ascertainmentC virus antibodyHeavy alcohol intakeConfidence intervalsFamily cancer historyImportant risk factorRandom digit dialingLow socioeconomic statusUnhealthy lifestyle choicesLower household incomeLogistic regression modelsNSAID useAlcohol intakeCigarette smokingHigher BMI
2017
Survivorship Care Preferences: A Pilot Study of Young Adults With Cancer
Viola A, Mitchell HR, Salner A, Gillan E, Rotatori J, Cartmel B, Santacroce S, Ma X, Kadan-Lottick N. Survivorship Care Preferences: A Pilot Study of Young Adults With Cancer. Clinical Journal Of Oncology Nursing 2017, 21: e71-e78. PMID: 29658261, DOI: 10.1188/17.cjon.e71-e78.Peer-Reviewed Original ResearchConceptsSurvivorship researchYoung adultsSurvivorship care plansMonths of diagnosisHealthcare team membersLate complicationsSurvivorship careConnecticut hospitalsCare plansCare preferencesSurvivorship studiesHealth concernPilot studyAYAsDiagnosisCancer therapyMonthsAdultsNovel strategyParticipantsComplicationsPatientsSarcomaLymphomaHospital
2008
Prevalence of polycythemia vera and essential thrombocythemia
Ma X, Vanasse G, Cartmel B, Wang Y, Selinger HA. Prevalence of polycythemia vera and essential thrombocythemia. American Journal Of Hematology 2008, 83: 359-362. PMID: 18181200, DOI: 10.1002/ajh.21129.Peer-Reviewed Original ResearchConceptsPrevalence of PVPolycythemia veraEssential thrombocythemiaMyeloproliferative disordersUS populationAge-standardized prevalenceHealth claims dataAge-specific prevalenceLarge US populationEntire US populationClaims dataET patientsInsurance payerHealth claimsLogistic regressionPrevalencePatientsMedicaid ServicesMolecular etiologyCommon typeThrombocythemiaDisordersUnited StatesAffected populationVera
2007
Clustering in the incidence of myelodysplastic syndromes
Ma X, Selvin S, Raza A, Foti K, Mayne ST. Clustering in the incidence of myelodysplastic syndromes. Leukemia Research 2007, 31: 1683-1686. PMID: 17507092, DOI: 10.1016/j.leukres.2007.03.032.Peer-Reviewed Original ResearchMeSH KeywordsCluster AnalysisConnecticutDemographyHumansIncidenceMyelodysplastic SyndromesNeoplasmsRegistriesConceptsIncidence of MDSMyelodysplastic syndromePopulation-based cancer registry dataEtiology of MDSPopulation-based dataCancer registry dataGroup of malignanciesPoor prognosisObscure etiologyPotential clusteringRegistry dataHigh incidenceEtiologic hypothesesLarger sample sizeIncidenceSyndromeP-valueEtiologyFuture studiesState of ConnecticutCensus tractsSample sizeIntriguing findingPrognosisMalignancy